Report overview
Sulfonamides (sulphonamides) are a group of man-made (synthetic) medicines that contain the sulfonamide chemical group. They may also be called sulfa drugs. Many people use the term sulfonamide imprecisely to refer only to antibiotics that have a sulfonamide functional group in their chemical structure.
This report aims to provide a comprehensive presentation of the global market for Sulphonamides, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sulphonamides. This report contains market size and forecasts of Sulphonamides in global, including the following market information:
Global Sulphonamides Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Sulphonamides Market Sales, 2018-2023, 2024-2029, (K MT)
Global top five Sulphonamides companies in 2022 (%)
The global Sulphonamides market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Orally Absorbable Sulfonamide Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Sulphonamides include Abbott Laboratories, Boehringer Ingelheim Pharmaceuticals, Bayer AG, GlaxoSmithKline, King Pharmaceuticals, Mylan Pharmaceuticals, Novartis International AG, Pfizer and Par Pharmaceutical, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Sulphonamides manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Sulphonamides Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K MT)
Global Sulphonamides Market Segment Percentages, by Type, 2022 (%)
Orally Absorbable Sulfonamide
Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)
Topical Agents (Silver sulfadiazine, sulfacetamide, mafenide)
Global Sulphonamides Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K MT)
Global Sulphonamides Market Segment Percentages, by Application, 2022 (%)
Skin Infections
Gastro Intestinal Tract (GIT) Infection
Meningitis
Global Sulphonamides Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K MT)
Global Sulphonamides Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Sulphonamides revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Sulphonamides revenues share in global market, 2022 (%)
Key companies Sulphonamides sales in global market, 2018-2023 (Estimated), (K MT)
Key companies Sulphonamides sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott Laboratories
Boehringer Ingelheim Pharmaceuticals
Bayer AG
GlaxoSmithKline
King Pharmaceuticals
Mylan Pharmaceuticals
Novartis International AG
Pfizer
Par Pharmaceutical
Roche Holding AG
Sanofi Aventis
Stiefel Laboratories
Outline of Major Chapters:
Chapter 1: Introduces the definition of Sulphonamides, market overview.
Chapter 2: Global Sulphonamides market size in revenue and volume.
Chapter 3: Detailed analysis of Sulphonamides manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Sulphonamides in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Sulphonamides capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
